Ignite Creation Date:
2024-05-05 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00561730
Status:
COMPLETED
Last Update Posted:
2012-05-08
First Post:
2007-11-12
Brief Title:
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease NERD or Erosive Gastroesophageal Reflux Disease eGERD
Sponsor:
Nycomed
Organization:
Nycomed
Study Overview
Official Title:
Pantoprazole 20 mg40 mg for the Treatment of Gastroesophageal Reflux Disease GERD
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PANTHER
Brief Summary:
The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD non-erosive reflux disease or eGERD erosive gastroesophageal reflux disease in clinical practice During the study the patients had to complete a short version of a patient-orientated self-assessed reflux questionnaire ReQuest in Practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None